VAR2 PHARMACEUTICALS APS has a total of 21 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in Australia, United States and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are CT HOSPITALIER UNIVERSITAIRE DE DIJON, ASCLEPIUMM LTD and MONOCLONAL ANTIBODIES THERAPEU.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | United States | 3 | |
#3 | Brazil | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Singapore | 2 | |
#8 | WIPO (World Intellectual Property Organization) | 2 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | Israel | 1 | |
#11 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Daugaard Mads | 11 |
#2 | Clausen Thomas Mandel | 10 |
#3 | Salanti Ali | 10 |
#4 | Theander Thor Grundtvig | 10 |
#5 | Nielsen Morten | 10 |
#6 | Zocca Mai-Britt | 6 |
#7 | Dahlback Madeleine | 5 |
#8 | Dahlbäck Madeleine | 3 |
#9 | Mads Daugaard | 3 |
#10 | Dahlbaeck Madeleine | 3 |
Publication | Filing date | Title |
---|---|---|
US2018298098A1 | Immunotherapeutic targeting of placental-like chondroitin sulfate using chimeric antigen receptors (cars) and immunotherapeutic targeting of cancer using cars with split-protein binding systems | |
AU2013217986A1 | Targeting of chondroitin sulfate glycans |